News for Kythera Biopharmaceuticals Inc - Google Finance

KYTHERA BIOPHARMACEUTICALS INC. : KYTHERA Biopharmaceuticals to ...

Tue, 07 May 2013 22:02:17 GMT

KYTHERA BIOPHARMACEUTICALS INC. : KYTHERA Biopharmaceuticals to ...
4-traders (press release) - May 7, 2013

LOS ANGELES, May 7, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that Keith Leonard, president and chief executive officer, will present at the Bank of America Merrill Lynch 2013 Healthcare ...

KYTHERA Biopharmaceuticals Announces First Quarter 2013 Operating Results

Mon, 13 May 2013 20:12:51 GMT

KYTHERA Biopharmaceuticals Announces First Quarter 2013 Operating Results
GlobeNewswire (press release) - May 13, 2013

LOS ANGELES, May 13, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today reported financial results for its first quarter 2013, and provided an update on recent accomplishments.

Kythera Biopharmaceuticals Now Covered by Thomson Reuters/Verus (KYTH)

Mon, 20 May 2013 20:17:11 GMT

Kythera Biopharmaceuticals Now Covered by Thomson Reuters/Verus (KYTH)
Daily Political - May 20, 2013

KYTHERA Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of prescription products for the aesthetic medicine market.

KYTHERA Biopharma To Present At Bank Of America Conference; Webcast At 2 ...

Tue, 14 May 2013 17:23:33 GMT

KYTHERA Biopharma To Present At Bank Of America Conference; Webcast At 2 ...
NASDAQ - May 14, 2013

(RTTNews.com) - KYTHERA Biopharmaceuticals, Inc. ( KYTH ) will present at the Bank of America Merrill Lynch 2013 Healthcare Conference in Las Vegas.

Esperion plans IPO to get drug to market

Sun, 05 May 2013 12:22:16 GMT

Esperion plans IPO to get drug to market
Crain's Detroit Business - May 5, 2013

based Merrimack Pharmaceuticals Inc. raised $100 million and Cambridge-based Verastem Inc., raised $55 million; New York-based Intercept Pharmaceuticals Inc. raised $75 million; and Calabasas, Calif.

DIARY-NON S&P WEEK AHEAD

Wed, 08 May 2013 10:42:02 GMT

DIARY-NON S&P WEEK AHEAD
Reuters - May 8, 2013

OF YEAR AGO ESTIMATE EST EPS 08 May AMC Q1 2013 AcelRx Pharmaceuticals, Inc. -0.27 8 -0.36 08 May AMC Q1 2013 ADA ES INC -0.20 3 -0.14 08 May AMC Q1 2013 American Financial Group 0.83 6 0.86 08 May AMC Q1 2013 Ashford Hospitality ..... Engility ...

Kythera Biopharmaceuticals Inc Announces Positive Magnetic Resonance Imaging (MRI) Results from Phase IIb Study of ATX-101 in Reduction of Submental Fat or 'Double Chin'

Sat, 13 Apr 2013 20:45:00 GMT

Kythera Biopharmaceuticals Inc Announces Positive Magnetic Resonance Imaging (MRI) Results from Phase IIb Study of ATX-101 in Reduction of Submental Fat or 'Double Chin'
Reuters Key Development - Apr 13, 2013

Kythera Biopharmaceuticals Inc Announces Positive Interim Results from Open-Label Study of ATX-101 in Reduction of Unwanted Submental Fat (SMF) or 'Double Chin'

Fri, 01 Mar 2013 14:10:00 GMT

Kythera Biopharmaceuticals Inc Announces Positive Interim Results from Open-Label Study of ATX-101 in Reduction of Unwanted Submental Fat (SMF) or 'Double Chin'
Reuters Key Development - Mar 1, 2013

Kythera Biopharmaceuticals Inc Announces Closing Of Initial Public Offering And Exercise Of Underwriters Over-allotment Option

Tue, 16 Oct 2012 14:48:00 GMT

Kythera Biopharmaceuticals Inc Announces Closing Of Initial Public Offering And Exercise Of Underwriters Over-allotment Option
Reuters Key Development - Oct 16, 2012

Kythera Biopharmaceuticals Inc Announces Pricing Of Initial Public Offering

Thu, 11 Oct 2012 11:00:00 GMT

Kythera Biopharmaceuticals Inc Announces Pricing Of Initial Public Offering
Reuters Key Development - Oct 11, 2012